{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:30:23Z","timestamp":1793694623200,"version":"4.5.1"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phrs.2026.109645","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T06:23:37Z","timestamp":1790576617000},"page":"109645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The TLR4\/MyD88 axis in cancer: Divergent and convergent roles of NF-\u03baB and NLRP3 inflammasome activation and therapeutic opportunities"],"prefix":"10.1016","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8852-3492","authenticated-orcid":false,"given":"Davood","family":"Zaeifi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadijeh","family":"Jamialahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phrs.2026.109645_bib1","doi-asserted-by":"crossref","DOI":"10.14218\/JERP.2025.00045","article-title":"Cancer and inflammation: immunologic interplay, translational advances, and clinical strategies","volume":"10","author":"Yang","year":"2025","journal-title":"J. Explor. Res. Pharmacol."},{"key":"10.1016\/j.phrs.2026.109645_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1568729","article-title":"TLR4\/MyD88 expression patterns and novel genetic variants: association with aggressive clinicopathological features in colorectal cancer","volume":"15","author":"Dang","year":"2025","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.phrs.2026.109645_bib3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","article-title":"Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy","volume":"170","author":"Yu","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s44272-024-00023-x","article-title":"MyD88's function in the emergence and growth of tumors","volume":"3","author":"Liu","year":"2024","journal-title":"Clin. Cancer Bull."},{"issue":"8","key":"10.1016\/j.phrs.2026.109645_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","article-title":"NF-kappaB in inflammation and cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.phrs.2026.109645_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2026.125248","article-title":"Advances in the regulation of NLRP3 inflammasome by natural polysaccharides: Structural features, mechanisms of action, and disease associations","volume":"382","author":"Xu","year":"2026","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12964-025-02416-4","article-title":"Review: Progress of the NLRP3 inflammasome in tumours and perspectives for cholangiocarcinoma","volume":"23","author":"Zhuo","year":"2025","journal-title":"Cell. Commun. Signal."},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib8","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s12672-025-02509-z","article-title":"The role of TLR-4 in chemoresistance of cancer","volume":"16","author":"Li","year":"2025","journal-title":"Discov. Oncol."},{"issue":"5","key":"10.1016\/j.phrs.2026.109645_bib9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/biom14050562","article-title":"MyD88 and Its Inhibitors in Cancer: Prospects and Challenges","volume":"14","author":"Song","year":"2024","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.phrs.2026.109645_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2183\/pjab.85.143","article-title":"Pathogen recognition by innate immunity and its signaling","volume":"85","author":"Akira","year":"2009","journal-title":"Proc. Jpn Acad. Ser. B Phys. Biol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2026.109645_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2026.109645_bib12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.molcel.2014.08.006","article-title":"IRAK4 dimerization and trans-autophosphorylation are induced by Myddosome assembly","volume":"55","author":"Ferrao","year":"2014","journal-title":"Mol. Cell."},{"issue":"7300","key":"10.1016\/j.phrs.2026.109645_bib13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature09121","article-title":"Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR\/IL-1R signalling","volume":"465","author":"Lin","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phrs.2026.109645_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0092-8674(00)00126-4","article-title":"Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain","volume":"103","author":"Deng","year":"2000","journal-title":"Cell"},{"issue":"6844","key":"10.1016\/j.phrs.2026.109645_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/35085597","article-title":"TAK1 is a ubiquitin-dependent kinase of MKK and IKK","volume":"412","author":"Wang","year":"2001","journal-title":"Nature"},{"issue":"7340","key":"10.1016\/j.phrs.2026.109645_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature09816","article-title":"Linear ubiquitination prevents inflammation and regulates immune signalling","volume":"471","author":"Gerlach","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phrs.2026.109645_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ncb1821","article-title":"Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation","volume":"11","author":"Tokunaga","year":"2009","journal-title":"Nat. Cell. Biol."},{"issue":"18","key":"10.1016\/j.phrs.2026.109645_bib18","doi-asserted-by":"crossref","first-page":"7966","DOI":"10.1128\/MCB.25.18.7966-7975.2005","article-title":"NF-kappaB RelA phosphorylation regulates RelA acetylation","volume":"25","author":"Chen","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"9","key":"10.1016\/j.phrs.2026.109645_bib19","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cellsig.2010.03.017","article-title":"Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway","volume":"22","author":"Huang","year":"2010","journal-title":"Cell. Signal."},{"issue":"10","key":"10.1016\/j.phrs.2026.109645_bib20","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/ni1110","article-title":"The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses","volume":"5","author":"Boone","year":"2004","journal-title":"Nat. Immunol."},{"issue":"6950","key":"10.1016\/j.phrs.2026.109645_bib21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature01802","article-title":"The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination","volume":"424","author":"Kovalenko","year":"2003","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.phrs.2026.109645_bib22","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ni.3538","article-title":"NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations","volume":"17","author":"Mortimer","year":"2016","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2017.08.017","article-title":"NLRP3 Phosphorylation Is an Essential Priming Event for Inflammasome Activation","volume":"68","author":"Song","year":"2017","journal-title":"Mol. Cell."},{"issue":"10","key":"10.1016\/j.phrs.2026.109645_bib24","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201744766","article-title":"USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation","volume":"19","author":"Palazon-Riquelme","year":"2018","journal-title":"EMBO Rep."},{"issue":"6","key":"10.1016\/j.phrs.2026.109645_bib25","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.celrep.2014.02.015","article-title":"Caspase-11 controls interleukin-1beta release through degradation of TRPC1","volume":"6","author":"Py","year":"2014","journal-title":"Cell. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib26","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1038\/s41467-018-05321-2","article-title":"SUMO-mediated regulation of NLRP3 modulates inflammasome activity","volume":"9","author":"Barry","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib27","doi-asserted-by":"crossref","first-page":"8396","DOI":"10.1038\/s41467-023-44203-0","article-title":"Acetylation is required for full activation of the NLRP3 inflammasome","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.phrs.2026.109645_bib28","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ni.2749","article-title":"Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity","volume":"14","author":"Hara","year":"2013","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2026.109645_bib29","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1084\/jem.20132486","article-title":"The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation","volume":"211","author":"Rodgers","year":"2014","journal-title":"J. Exp. Med."},{"issue":"7610","key":"10.1016\/j.phrs.2026.109645_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature18629","article-title":"Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature"},{"issue":"7575","key":"10.1016\/j.phrs.2026.109645_bib31","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.109645_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1627084","article-title":"Post-translational governance of NF-kappaB in cancer immunity: mechanisms and therapeutic horizons","volume":"16","author":"Hong","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.109645_bib33","article-title":"Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules","volume":"11","author":"Seok","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.phrs.2026.109645_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012287","article-title":"Therapeutic inhibition of USP7 promotes antitumor immune responses","volume":"13","author":"Muchowicz","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.phrs.2026.109645_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116130","article-title":"Protein lysine acetyltransferase CBP\/p300: a promising target for small molecules in cancer treatment","volume":"171","author":"Gou","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.phrs.2026.109645_bib36","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.joca.2013.09.008","article-title":"Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1beta signaling in osteoarthritis fibroblast-like synoviocytes","volume":"21","author":"Wang","year":"2013","journal-title":"Osteoarthr. Cartil."},{"issue":"12","key":"10.1016\/j.phrs.2026.109645_bib37","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1038\/s41591-023-02635-7","article-title":"IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial","volume":"29","author":"Ackerman","year":"2023","journal-title":"Nat. Med."},{"issue":"16","key":"10.1016\/j.phrs.2026.109645_bib38","doi-asserted-by":"crossref","first-page":"17874","DOI":"10.1021\/acs.jmedchem.5c01620","article-title":"Discovery of Rigid Linker-Based IRAK4 PROTACs with Improved Metabolic Stability for the Treatment of Inflammatory Diseases","volume":"68","author":"Fan","year":"2025","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.phrs.2026.109645_bib39","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.3390\/cancers16193324","article-title":"p66Shc protein-oxidative stress sensor or redox enzyme: its potential role in mitochondrial metabolism of human breast cancer","volume":"16","author":"Prill","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"14","key":"10.1016\/j.phrs.2026.109645_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70737","article-title":"The role of p66Shc in cancer: molecular mechanisms and therapeutic implications","volume":"29","author":"Zaeifi","year":"2025","journal-title":"J. Cell. Mol. Med."},{"issue":"12","key":"10.1016\/j.phrs.2026.109645_bib41","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/carcin\/bgad072","article-title":"Interplay between inflammasomes and PD-1\/PD-L1 and their implications in cancer immunotherapy","volume":"44","author":"Jiao","year":"2023","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.phrs.2026.109645_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218314","article-title":"Cancer cell metastasis and drug resistance: Unravelling the role of NF-kappaB and cyclin D1 pathways and their crosstalk","volume":"643","author":"Dey","year":"2026","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13008-024-00133-x","article-title":"MiR-5195-3p predicts clinical prognosis and represses colorectal cancer progression by targeting TLR4\/MyD88 signaling","volume":"19","author":"Lv","year":"2024","journal-title":"Cell. Div."},{"issue":"5","key":"10.1016\/j.phrs.2026.109645_bib44","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.bjc.6605558","article-title":"High expression of Toll-like receptor 4\/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer","volume":"102","author":"Wang","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"7371","key":"10.1016\/j.phrs.2026.109645_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature10558","article-title":"Non-canonical inflammasome activation targets caspase-11","volume":"479","author":"Kayagaki","year":"2011","journal-title":"Nature"},{"issue":"7521","key":"10.1016\/j.phrs.2026.109645_bib46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature13683","article-title":"Inflammatory caspases are innate immune receptors for intracellular LPS","volume":"514","author":"Shi","year":"2014","journal-title":"Nature"},{"issue":"7575","key":"10.1016\/j.phrs.2026.109645_bib47","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2026.109645_bib48","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cell.2012.07.007","article-title":"TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria","volume":"150","author":"Rathinam","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2026.109645_bib49","article-title":"Research and progress of cGAS\/STING\/NLRP3 signaling pathway: a mini review","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12964-023-01466-w","article-title":"cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation","volume":"22","author":"Liu","year":"2024","journal-title":"Cell. Commun. Signal."},{"issue":"8","key":"10.1016\/j.phrs.2026.109645_bib51","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00262-025-04088-y","article-title":"NLRP3 activation promotes cGAS\/STING signaling and antitumor immunity by colorectal cancer cells","volume":"74","author":"Mowat","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"issue":"7","key":"10.1016\/j.phrs.2026.109645_bib52","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.4049\/jimmunol.1000803","article-title":"Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia","volume":"185","author":"Lamkanfi","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib53","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1186\/s12964-024-01909-y","article-title":"Exploring the role of Fusobacterium nucleatum in colorectal cancer: implications for tumor proliferation and chemoresistance","volume":"22","author":"Dadgar-Zankbar","year":"2024","journal-title":"Cell. Commun. Signal."},{"issue":"4","key":"10.1016\/j.phrs.2026.109645_bib54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phrs.2026.109645_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103028","article-title":"p66ShcA promotes malignant breast cancer phenotypes by alleviating energetic and oxidative stress","volume":"70","author":"Lewis","year":"2024","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.phrs.2026.109645_bib56","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.immuni.2010.03.003","article-title":"The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis","volume":"32","author":"Zaki","year":"2010","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.phrs.2026.109645_bib57","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.4049\/jimmunol.1002046","article-title":"IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation","volume":"185","author":"Zaki","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2026.109645_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.877495","article-title":"p66Shc Deficiency in Chronic Lymphocytic Leukemia Promotes Chemokine Receptor Expression Through the ROS-Dependent Inhibition of NF-kappaB","volume":"12","author":"Tatangelo","year":"2022","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.phrs.2026.109645_bib59","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.immuni.2008.02.002","article-title":"The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals","volume":"28","author":"Hitotsumatsu","year":"2008","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.phrs.2026.109645_bib60","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"issue":"5838","key":"10.1016\/j.phrs.2026.109645_bib61","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.1142953","article-title":"Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade","volume":"317","author":"Carmody","year":"2007","journal-title":"Science"},{"issue":"48","key":"10.1016\/j.phrs.2026.109645_bib62","doi-asserted-by":"crossref","first-page":"49995","DOI":"10.1074\/jbc.M404246200","article-title":"BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages","volume":"279","author":"Wessells","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.phrs.2026.109645_bib63","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1084\/jem.194.8.1021","article-title":"c-Rel regulates interleukin 12 p70 expression in CD8(+) dendritic cells by specifically inducing p35 gene transcription","volume":"194","author":"Grumont","year":"2001","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.phrs.2026.109645_bib64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1074-7613(02)00272-8","article-title":"Dendritic cell development and survival require distinct NF-kappaB subunits","volume":"16","author":"Ouaaz","year":"2002","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.phrs.2026.109645_bib65","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231348","article-title":"NF-kappaB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer","volume":"221","author":"Lalle","year":"2024","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.phrs.2026.109645_bib66","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1435250","article-title":"NF-kappaB RelA renders tumor-associated macrophages resistant to and capable of directly suppressing CD8(+) T cells for tumor promotion","volume":"7","author":"Li","year":"2018","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.7150\/ijbs.123482","article-title":"Dual-pathway mechanism of vanadium-induced hepatotoxicity in ducks: synergistic crosstalk between glucose homeostasis disruption and NADH\/FSP1\/COQ10 axis-driven ferroptosis","volume":"22","author":"Chen","year":"2026","journal-title":"Int. J. Biol. Sci."},{"issue":"9","key":"10.1016\/j.phrs.2026.109645_bib68","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/embor.2008.136","article-title":"The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response","volume":"9","author":"Friedman","year":"2008","journal-title":"EMBO Rep."},{"issue":"2","key":"10.1016\/j.phrs.2026.109645_bib69","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0092-8674(02)00827-9","article-title":"IRAK-M is a negative regulator of Toll-like receptor signaling","volume":"110","author":"Kobayashi","year":"2002","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.phrs.2026.109645_bib70","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/onc.2010.619","article-title":"TGF-beta-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth","volume":"30","author":"Standiford","year":"2011","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.phrs.2026.109645_bib71","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.phrs.2026.109645_bib72","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ni968","article-title":"SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling","volume":"4","author":"Wald","year":"2003","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2026.109645_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.seminoncol.2025.152455","article-title":"LncRNAs in inflammasome regulation: Orchestrating cancer signaling and chemoresistance","volume":"53","author":"Mukhlif","year":"2026","journal-title":"Semin. Oncol."},{"issue":"33","key":"10.1016\/j.phrs.2026.109645_bib74","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7247","key":"10.1016\/j.phrs.2026.109645_bib75","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"issue":"7247","key":"10.1016\/j.phrs.2026.109645_bib76","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature07969","article-title":"Frequent inactivation of A20 in B-cell lymphomas","volume":"459","author":"Kato","year":"2009","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.phrs.2026.109645_bib77","first-page":"5033","article-title":"Multiple roles of microRNA-146a in immune responses and hepatocellular carcinoma","volume":"18","author":"Wang","year":"2019","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib78","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1038\/s41467-021-22641-y","article-title":"MicroRNA-146a limits tumorigenic inflammation in colorectal cancer","volume":"12","author":"Garo","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2026.109645_bib79","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.4049\/jimmunol.1201516","article-title":"NLRP3 inflammasome activity is negatively controlled by miR-223","volume":"189","author":"Bauernfeind","year":"2012","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2026.109645_bib80","first-page":"2180","article-title":"NLRP3 inflammasome inactivation driven by miR\u2011223\u20113p reduces tumor growth and increases anticancer immunity in breast cancer","volume":"19","author":"Zhang","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib81","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41467-019-09482-6","article-title":"The lncRNA Neat1 promotes activation of inflammasomes in macrophages","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.phrs.2026.109645_bib82","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2017.09.039","article-title":"The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3","volume":"171","author":"Gaidt","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2026.109645_bib83","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.freeradbiomed.2026.05.300","article-title":"Vanadium exposure promotes pulmonary fibrosis via crosstalk between cGAS-STING\/NF-kappaB and Wnt signaling in ducks","volume":"253","author":"Chu","year":"2026","journal-title":"Free. Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2026.109645_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.591803","article-title":"Interplay Between NLRP3 Inflammasome and Autophagy","volume":"11","author":"Biasizzo","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2026.109645_bib85","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41423-025-01284-9","article-title":"Updated insights into the molecular networks for NLRP3 inflammasome activation","volume":"22","author":"Paik","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2026.109645_bib86","doi-asserted-by":"crossref","first-page":"E961","DOI":"10.1073\/pnas.1613305114","article-title":"Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner","volume":"114","author":"Conos","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2026.109645_bib87","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1038\/ncomms7282","article-title":"RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL","volume":"6","author":"Lawlor","year":"2015","journal-title":"Nat. Commun."},{"issue":"7237","key":"10.1016\/j.phrs.2026.109645_bib88","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature07710","article-title":"AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA","volume":"458","author":"Fernandes-Alnemri","year":"2009","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.phrs.2026.109645_bib89","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ni.1864","article-title":"The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses","volume":"11","author":"Rathinam","year":"2010","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2026.109645_bib90","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cell.2013.02.054","article-title":"The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation","volume":"153","author":"Subramanian","year":"2013","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.phrs.2026.109645_bib91","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.phrs.2026.109645_bib92","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006781","article-title":"Pyroptosis activates conventional type I dendritic cells to mediate the priming of highly functional anticancer T cells","volume":"12","author":"Inkol","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.phrs.2026.109645_bib93","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3389\/fimmu.2020.01444","article-title":"NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2026.109645_bib94","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.phrs.2026.109645_bib95","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","article-title":"Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor","volume":"6","author":"Coppe","year":"2008","journal-title":"PLoS. Biol."},{"issue":"8","key":"10.1016\/j.phrs.2026.109645_bib96","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ncb3195","article-title":"MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation","volume":"17","author":"Laberge","year":"2015","journal-title":"Nat. Cell. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib97","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12943-025-02475-8","article-title":"The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy","volume":"24","author":"Cao","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib98","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12943-024-02096-7","article-title":"Cellular senescence and SASP in tumor progression and therapeutic opportunities","volume":"23","author":"Dong","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib99","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","article-title":"Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation","volume":"24","author":"Lampropoulou","year":"2016","journal-title":"Cell. Metab."},{"issue":"7444","key":"10.1016\/j.phrs.2026.109645_bib100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phrs.2026.109645_bib101","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","article-title":"Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/beta-catenin signaling via its FadA adhesin","volume":"14","author":"Rubinstein","year":"2013","journal-title":"Cell. Host Microbe"},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib102","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/s41467-024-45572-w","article-title":"Fusobacterium nucleatum promotes tumor progression in KRAS p.G12D-mutant colorectal cancer by binding to DHX15","volume":"15","author":"Zhu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.109645_bib103","doi-asserted-by":"crossref","DOI":"10.1038\/s41579-026-01351-6","article-title":"Bacterial lipid structural diversity mediates commensalism and pathogenesis","author":"Heaver","year":"2026","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.phrs.2026.109645_bib104","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/s41564-025-01930-y","article-title":"Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses","volume":"10","author":"Sardar","year":"2025","journal-title":"Nat. Microbiol."},{"issue":"11","key":"10.1016\/j.phrs.2026.109645_bib105","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1021\/jacsau.5c00810","article-title":"Fusobacterium nucleatum Lipopolysaccharides O\u2011Antigen Defines a Novel Siglec\u20117 Binding Epitope","volume":"5","author":"Di Carluccio","year":"2025","journal-title":"JACS Au"},{"key":"10.1016\/j.phrs.2026.109645_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.658681","article-title":"Fusobacterium nucleatum Facilitates M2 Macrophage Polarization and Colorectal Carcinoma Progression by Activating TLR4\/NF-kappaB\/S100A9 Cascade","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2026.109645_bib107","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","article-title":"Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment","volume":"14","author":"Kostic","year":"2013","journal-title":"Cell. Host Microbe"},{"issue":"9","key":"10.1016\/j.phrs.2026.109645_bib108","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/nm.2015","article-title":"A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses","volume":"15","author":"Wu","year":"2009","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.phrs.2026.109645_bib109","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1073\/pnas.1322269111","article-title":"The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition","volume":"111","author":"Chang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2026.109645_bib110","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1038\/ncomms7734","article-title":"Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome","volume":"6","author":"Macia","year":"2015","journal-title":"Nat. Commun."},{"issue":"6356","key":"10.1016\/j.phrs.2026.109645_bib111","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.phrs.2026.109645_bib112","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184321","article-title":"The gut microbiome and cancer response to immune checkpoint inhibitors","volume":"135","author":"Gazzaniga","year":"2025","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib113","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41522-025-00786-8","article-title":"Gut microbiota shapes cancer immunotherapy responses","volume":"11","author":"Lei","year":"2025","journal-title":"NPJ Biofilms Micro"},{"issue":"7332","key":"10.1016\/j.phrs.2026.109645_bib114","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.phrs.2026.109645_bib115","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.109645_bib116","article-title":"Molecular insights into NLRP3 inflammasome and miRNA modulation in oral cancer","volume":"16","author":"Mannino","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2026.109645_bib117","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.0610731104","article-title":"MicroRNA-155 is induced during the macrophage inflammatory response","volume":"104","author":"O'Connell","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.phrs.2026.109645_bib118","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.4049\/jimmunol.179.8.5082","article-title":"Modulation of miR-155 and miR-125b levels following lipopolysaccharide\/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock","volume":"179","author":"Tili","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib119","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.immuni.2008.11.010","article-title":"Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein","volume":"30","author":"Lu","year":"2009","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib120","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41467-017-00972-z","article-title":"An NF-kappaB-microRNA regulatory network tunes macrophage inflammatory responses","volume":"8","author":"Mann","year":"2017","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.phrs.2026.109645_bib121","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1073\/pnas.0902636106","article-title":"Inositol phosphatase SHIP1 is a primary target of miR-155","volume":"106","author":"O'Connell","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.phrs.2026.109645_bib122","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1158\/0008-5472.CAN-14-2331","article-title":"Host miR155 promotes tumor growth through a myeloid-derived suppressor cell-dependent mechanism","volume":"75","author":"Chen","year":"2015","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.phrs.2026.109645_bib123","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/cells14070544","article-title":"The Role of A20 in Cancer: Friend or Foe?","volume":"14","author":"Lee","year":"2025","journal-title":"Cells"},{"issue":"32","key":"10.1016\/j.phrs.2026.109645_bib124","doi-asserted-by":"crossref","first-page":"52032","DOI":"10.18632\/oncotarget.10496","article-title":"sTLR4\/MD-2 complex inhibits colorectal cancer in vitro and in vivo by targeting LPS","volume":"7","author":"Zou","year":"2016","journal-title":"Oncotarget"},{"issue":"1-3","key":"10.1016\/j.phrs.2026.109645_bib125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-5793(03)00747-6","article-title":"MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB- and AP-1-dependent gene expression","volume":"548","author":"Janssens","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2026.109645_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.616451","article-title":"Absence of Non-Canonical, Inhibitory MYD88 Splice Variants in B Cell Lymphomas Correlates With Sustained NF-kappaB Signaling","volume":"12","author":"Cardona Gloria","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.phrs.2026.109645_bib127","doi-asserted-by":"crossref","first-page":"11073","DOI":"10.1007\/s00210-025-04030-0","article-title":"NLRP3 inflammasome-based therapies by natural products: a new development in the context of cancer therapy","volume":"398","author":"Owida","year":"2025","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2026.109645_bib128","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1007\/s10787-025-01926-4","article-title":"Targeting NLRP3 inflammasome with curcumin: mechanisms and therapeutic promise in chronic inflammation","volume":"33","author":"Pandey","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib129","article-title":"vivo mechanisms of resveratrol liposomes in targeting the TLR4\/NLRP3 pathway in lung cancer","volume":"15","author":"Chen","year":"2025","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.phrs.2026.109645_bib130","article-title":"Honokiol-Magnolol-Baicalin Possesses Synergistic Anticancer Potential and Enhances the Efficacy of Anti-PD-1 Immunotherapy in Colorectal Cancer by Triggering GSDME-Dependent Pyroptosis","volume":"12","author":"Gao","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"1","key":"10.1016\/j.phrs.2026.109645_bib131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s40104-025-01255-0","article-title":"LAPTM4B as a key regulator in the copper-induced endoplasmic reticulum-lysosome interplay disorder in duck liver and the protective role of baicalin","volume":"16","author":"Shang","year":"2025","journal-title":"J. Anim. Sci. Biotechnol."},{"issue":"6","key":"10.1016\/j.phrs.2026.109645_bib132","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1007\/s10787-024-01566-0","article-title":"The role of quercetin in NLRP3-associated inflammation","volume":"32","author":"Wu","year":"2024","journal-title":"Inflammopharmacology"},{"issue":"9","key":"10.1016\/j.phrs.2026.109645_bib133","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1039\/D3NR05570A","article-title":"Nanoparticle-mediated co-delivery of inflammasome inhibitors provides protection against sepsis","volume":"16","author":"Nandi","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.phrs.2026.109645_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122533","article-title":"MDSC-targeting gold nanoparticles enhance PD-1 tumor immunotherapy by inhibiting NLRP3 inflammasomes","volume":"307","author":"Zhu","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2026.109645_bib135","doi-asserted-by":"crossref","DOI":"10.1039\/D6BM00242K","article-title":"Dendrimers in precision oncology: advances in therapy, diagnostics, and translational prospects","author":"Zaeifi","year":"2026","journal-title":"Biomater. Sci."},{"issue":"11","key":"10.1016\/j.phrs.2026.109645_bib136","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00018-017-2720-9","article-title":"Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma","volume":"75","author":"Chen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.phrs.2026.109645_bib137","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826015604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826015604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:17:03Z","timestamp":1793693823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826015604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":137,"alternative-id":["S1043661826015604"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.109645","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The TLR4\/MyD88 axis in cancer: Divergent and convergent roles of NF-\u03baB and NLRP3 inflammasome activation and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.109645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109645"}}